2nd September 2024
2nd September 2024
Vaccination against COVID-19 in the winter of 2024-2025
A COVID-19 vaccine is available from the distributor. The vaccine that will be used in vaccinations in the winter of 2024-2025 according to contracts from the Ministry of Health is a Comirnaty JN.1 vaccines.
-Automatic translation
Vaccination is recommended only for risk groups from 5 years of age and priority groups with this updated vaccine against the omicron subtypes that have been dominated this year. The website of the Directorate of Health can be found special instruction for COVID-19 vaccination.
The vaccine may be given at the same time as an influenza vaccine. The risk and priority groups are almost the same for both vaccines, but vaccinators can choose to offer COVID-19 vaccinations before influenza vaccinations can begin. It is also recommended that two weeks should be between vaccinations if possible, to reduce the risk of side effects of one vaccine being written on the other. If there is a reason, such as travel, then the vaccines can be given at shorter intervals.
The Chief Epidemiologist recommends that the following priority be given to COVID-19 vaccinations:
All individuals 60 years and older.
All children and adults who suffer from chronic heart, lung, kidney and liver disease, obesity, diabetes, malignancies or are immunocompromised by medicines or diseases.
Vaccination is offered to the following groups if epidemiology or something in the situation of individuals or institutions gives reason to the opinion of the parties concerned:
Pregnant women, after the first trimester of pregnancy.
Healthcare professionals who care for individuals in the above mentioned areas.
The vaccine is free to priority groups.
The parties that provide COVID-19 vaccination are healthcare centers, nursing homes, hospitals and certain pharmacies where an agreement has been made with healthcare and/or authorities. Media or websites of institutions and companies are indicated for advertisements on vaccination arrangements at local level.
The Chief Epidemiologist